The recall of the 5,400 bottles has been voluntarily initiated by the company through its US based arm Zydus Pharmaceuticals USA Inc. WASHINGTON: Drug firm Cadila Healthcare is voluntarily recalling 5,400 bottles of anti-hypertension drug Atenolol tablets, in ... Economic Times, 1 month ago
Cadila Healthcare recalls anti-hypertension drug in US - Hindu Business Line, 1 month ago
Cadila recalls drug in US - Calcutta Telegraph, 1 month ago
3 images for "zydus cadila"
Cadila Healthcare closed today at 1.15% at Rs. 1,272 on BSE. The stock opened at Rs. 1,300 and closed at Rs. 1,272. The stock hit a high of Rs. 1323 and a low of Rs. 1,262. Zydus Cadila has received tentative approval from the USFDA to market ...India Infoline, 2 months ago Cadila Health up 3%, diabetic drug gets tentative USFDA nod Money Control, 2 months ago Zydus gets USFDA tentative nod for diabetic tablets Press Trust of India, 2 months ago Zydus gets tentative nod for Glipizide ER tablets MyIris, 2 months ago
You currently are not registered for any FirstWord Pharma services. Register to FirstWord Pharma for free access to 10 articles every 30 days: You can also: Wait 12 days for your content allowance to be renewed. Sign up for a free trial to ...FirstWord Pharma, 2 weeks ago Cadila Healthcare Q2 net up 52% at Rs 278 crore The Financial Chronicle, 2 weeks ago Zydus Cadila Q2 net up 52% at Rs 278 cr Sify, 2 weeks ago Cadila Healthcare Q2 Net Rises 52% NDTV Profit, 2 weeks ago
Companies like Intas Pharma, Torrent Pharma, Zydus Cadila etc already have facilities in Sikkim Sohini Das | Ahmedabad November 2, 2014 Last Updated at 20:58 IST Vadodara-based pharma company Alembic Pharmaceuticals is all set to commission its formulations ...Business Standard, 3 weeks ago
Zydus Cadila COO and executive director Ganesh Nayak on how skeet shooting helps him keep his eyes trained on business goals Growing up in Bombay, Ganesh Nayak spent all his free time reading the iconic Phantom comic series, fascinated by the Lee Falk-created ...Outlook, 1 month ago
With an eye on the growing biologics market, Ahmedabad-based pharma major Cadila Healthcare (Zydus Cadila) is planning to mark its presence in the segment. The company plans to launch one to three products by next year, and hopes to have a portfolio ...Business Standard India, 1 month ago Zydus Cadila bags license for hepatitis C drug Business Standard, 2 months ago
Zydus Cadila has received tentative approval from the US FDA (Food and Drug Administration) to market Glipizide Extended-release (ER) tablets in the strengths of 2.5 mg, 5 mg, and 10 mg. The drug falls in the ant-diabetic segment. The estimated ...Indian-Commodity, 2 months ago Cadila Healthcar - Zydus receives tentative approval for Gli... SBICAP Securities, 2 months ago India : TENTATIVE Approval for Glipizide ER Tablets received by Zydus [TendersInfo (India)] Pharmacy Choice, 2 months ago Zydus receives tentative approval for Glipizide ER tablets Money Control, 2 months ago
Homegrown drug major Zydus Cadila has set a target of clocking a consolidated turnover of over Rs 10,000 crore by FY'16. "We will have a revenue of Rs 10,000 crore in FY16. We closed last fiscal with a revenue of Rs 7,208 crore," Zydus Cadila Chief ...Business Standard, 2 months ago Zydus Cadila sets Rs 10,000 crore sales target by FY16 Economic Times, 2 months ago
Supernus Pharmaceuticals, Inc. ( SUPN ) has filed a patent infringement lawsuit against Zydus Pharmaceuticals ( USA ) Inc. and Cadila Healthcare Limited accusing them of infringement of three patents covering Supernus antiepileptic drug, Trokendi ...Yahoo! Finance, 1 day ago
Supernus files lawsuit against Zydus in US court for infringement of patents covering its antiepileptic drug, Trokendi XR
Supernus Pharmaceuticals, a specialty pharmaceutical company focused on developing and commercializing products for the treatment of CNS disease, sannounced that it sued generic drug makers Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare ...PharmaBiz, 2 days ago Supernus Pharmaceuticals Files Lawsuit Against Zydus Pharmaceuticals (USA) Inc. In U.S. Court For Infringement Of Patents Covering Its Antiepileptic Drug, Trokendi XR BioSpace, 21 hours ago
on your WebpageAdd Widget >Get your members hooked!